Arrowstreet Capital, Limited Partnership Astrazeneca PLC Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 261,335 shares of AZN stock, worth $16.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
261,335Holding current value
$16.9 Million% of portfolio
0.02%Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
489MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.19 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...